ESCALON MEDICAL CORP (ticker: ESMC) is an OTC-listed electromedical & electrotherapeutic apparatus company. DredgeCap's structured extraction of ESMC's SEC filings surfaces 14 active risk signals, including 11 late-filing signals, 2 auditor-change signals, and 1 delisting/deregistration signal. ESMC reported $9.48M in revenue and -$142K for the period ending 2025-03-31, with operating cash flow of -$432K. Cash and equivalents stood at $337K (down 35.2% year-over-year). Total assets of $4.69M exceed total liabilities of $3.21M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
ESMC SEC Filings
Full cached SEC EDGAR filing history for ESMC, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.